Novo Nordisk cuts guidance as weight-loss drug market competition grows

Why did the Fed hold rates amid tariff uncertainty? How will US-China trade talks impact markets? What caused WeightWatchers to file for bankruptcy? Why is Newark Airport experiencing flight disruptions? How are Trump tariffs affecting US manufacturers? What explains Netflix's latest homepage redesign? Why did CrowdStrike announce job cuts? How is Disney thriving despite economic concerns? What led to Ford raising prices on Mexico-made cars?

Novo Nordisk cuts guidance as weight-loss drug market competition grows

euronews.com/business/2025/05/07/novo-nordisk-cuts-guidance-as-weight-loss-drug-market-competition-grows

Novo Nordisk shares jumped following stronger-than-expected first-quarter earnings, despite the company lowering its growth outlook for 2025 amid intensifying competition in the weight-loss drug markets.

This story appeared on euronews.com, 2025-05-07 09:06:18.